NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-074-2012-0-NO-19 Organic Compounds NO EP 13738252.9 Issued
NCATS E-074-2012-0-DK-12 Organic Compounds DK EP 13738252.9 Issued
NCATS E-074-2012-0-FR-14 Organic Compounds FR EP 13738252.9 Issued
NCATS E-074-2012-0-DE-11 Organic Compounds DE EP 13738252.9 Issued
NCATS E-074-2012-0-BE-09 Organic Compounds BE EP 13738252.9 Issued
NCATS E-074-2012-0-IT-16 Organic Compounds IT EP 13738252.9 Issued
NCATS E-074-2012-0-SE-20 Organic Compounds SE EP 13738252.9 Issued
NCATS E-074-2012-0-ES-13 Organic Compounds ES EP 13738252.9 Issued
NCATS E-074-2012-0-CH-10 Organic Compounds CH EP 13738252.9 Issued
NCATS E-074-2012-0-GB-15 Organic Compounds GB EP 13738252.9 Issued
NCATS E-074-2012-0-LU-17 Organic Compounds LU EP 13738252.9 Issued
NCATS E-074-2012-0-EP-06 Organic Compounds EP National Stage 13738252.9 Issued
NCATS E-074-2012-0-AU-03 Organic Compounds AU National Stage 2013209884 Issued
NCATS E-074-2012-0-CN-05 Organic Compounds CN National Stage 201380010564.7 Issued
NCI E-273-2009-0-US-03 Adoptive Cell Therapy With Young T Cells US DIV 13/742,541 9074185 Issued PDF
NIAID E-145-2004-3-US-04 Monoclonal Antibodies Against Orthopoxviruses US DIV 13/742,480 8999336 Issued PDF
NCATS E-074-2012-0-PCT-02 Organic Compounds PCT PCT PCT/US2013/021749 Expired
NIAID E-133-2012-0-US-01 Novel Attenuated Vaccine US 61/753,320 Abandoned
NCATS E-298-2011-1-US-01 Activators Of Human Pyruvate Kinase US 61/752,698 Abandoned
NCI E-103-2010-1-US-03 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins. US National Stage 13/699,535 8911728 Issued PDF
NIDA E-234-2005-1-US-05 Benztropine Compounds And Uses Thereof US DIV 13/739,724 Abandoned
NCI E-167-1997-0-JP-26 The Use of Nitroxide or a Prodrug Thereof In The Prophylactic And Therapeutic Treatment of Cancer JP DIV 2013-003496 Abandoned
NINDS E-133-2006-1-JP-13 Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses JP DIV 2013-004082 Abandoned
NIA E-078-2008-0-US-01 Empty Viral Particle-Based Safe Immunotherapeutics For Treatment Of Alzheimer's Disease US 61/751,769 Abandoned
NCI E-029-2006-1-JP-12 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment JP DIV 2013-002845 Issued
NIAID E-019-2007-2-JP-14 Influenza Hemagglutinin and Neuramindase Variants JP DIV 2013-000771 Abandoned
NHLBI E-207-2011-1-PCT-01 Multilayer-coated Micro Grating Array For X-ray Phase Sensitive and Scattering Sensitive Imaging PCT PCT PCT/US2013/020561 Expired
NCI E-233-2004-0-US-11 Live Microbial Microbicides US DIV 13/735,638 Abandoned
NCI E-001-2012-0-CA-04 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen CA National Stage 2860599 Issued
NCI E-001-2012-0-JP-07 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen JP National Stage 2014-551304 Issued
NCI E-001-2012-0-BE-08 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen BE EP 13700352.1 Issued
NCI E-001-2012-0-DE-10 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen DE EP 13700352.1 Issued
NCI E-001-2012-0-FR-13 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen FR EP 13700352.1 Issued
NCI E-001-2012-0-DK-11 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen DK EP 13700352.1 Issued
NCI E-001-2012-0-NL-16 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen NL EP 13700352.1 Issued
NCI E-001-2012-0-CH-09 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen CH EP 13700352.1 Issued
NCI E-001-2012-0-GB-14 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen GB EP 13700352.1 Issued
NCI E-001-2012-0-SE-17 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen SE EP 13700352.1 Issued
NCI E-001-2012-0-ES-12 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen ES EP 13700352.1 Issued
NCI E-001-2012-0-IE-15 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen IE EP 13700352.1 Issued
NCI E-001-2012-0-EP-05 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen EP National Stage 13700352.1 Issued
NCI E-001-2012-0-AU-03 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen AU National Stage 2013206896 Issued
NCI E-042-2012-0-AU-03 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions AU National Stage 2013208308 Abandoned
NCI E-001-2012-0-PCT-02 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen PCT PCT PCT/US2013/020058 Expired
NCI E-042-2012-0-PCT-02 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions. PCT PCT PCT/US13/20051 Expired
NIA E-165-2011-0-PCT-02 Human Soluble Receptor For Advanced Glycation End Products (sRAGE) Methods of Preparing Human Srage, And Treatment Methods Using Srage PCT PCT PCT/US2013/020103 Expired
NCI E-042-2012-0-EP-05 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions. EP National Stage 13736174.7 Abandoned
NCI E-042-2012-0-CA-04 Methods Of Treating Or Preventing Insulin Resistance And Associated Diseases and Conditions CA National Stage 2860842 Abandoned
NIA E-088-2007-1-CA-03 Methods For Modulating Embryonic Stem Cell Differentiation CA National Stage 2678901 Issued
NIAID E-154-2010-1-US-03 METHODS FOR THE INDUCTION OF EBOLA VIRUS-SPECIFIC IMMUNE RESPONSES COMPRISING ADMINISTERING A REPLICATION-DEFECTIVE CHIMPANZEE ADENOVIRUS VECTOR EXPRESSING THE EBOLA VIRUS GLYCOPRETEIN US National Stage 13/641,655 9526777 Issued PDF